Topotecan: all 270 studies that test it

Page 3 of 3. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's LymphomaCompletedNCT00038545Phase 2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00033696Phase 2
• Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00028925Phase 2
• Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00028743Phase 3
• Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the BrainCompletedNCT00025311Phase 1
• Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00025272Phase 2
• ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00014690Phase 2
• Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant GliomaTerminatedNCT00014443Phase 2
• Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial CancerCompletedNCT00006454Phase 3
• Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00006391Phase 1
• Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerWithdrawnNCT00006374Phase 2
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's LymphomaCompletedNCT00006373Phase 2
• Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32)Status unknownNCT00006199Phase 1
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaCompletedNCT00006125Phase 2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerTerminatedNCT00006032Phase 2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00006012Phase 1/2
• R115777 Plus Topotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00005990Phase 1
• Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous TreatmentCompletedNCT00005811Phase 2
• A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and EtoposideCompletedNCT00005793Phase 1/2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00005792Phase 1
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial CancerTerminatedNCT00005612Phase 1/2
• Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic SyndromeCompletedNCT00005593Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial CancerCompletedNCT00005051Phase 2
• Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerTerminatedNCT00005029Phase 2
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00005026Phase 1
• Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or LymphomaCompletedNCT00005021Phase 1
• Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid TumorsCompletedNCT00004979Phase 1/2
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian CancerTerminatedNCT00004221Phase 2
• Combination Chemotherapy in Treating Patients With Small Cell Lung CancerCompletedNCT00004186Phase 1/2
• S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00004137Phase 2
• Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00004055Phase 2
• Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00003967Phase 1
• Combination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaCompletedNCT00003958Phase 3
• Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical CancerCompletedNCT00003945Phase 3
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00003944Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.CompletedNCT00003943Phase 2
• Topotecan in Treating Patients With Relapsed Small Cell Lung CancerCompletedNCT00003917Phase 3
• Combination Chemotherapy in Treating Patients With Myelodysplastic SyndromeStatus unknownNCT00003827Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00003812Phase 2
• Chemotherapy in Treating Children With Recurrent or Refractory SarcomasCompletedNCT00003745Phase 2
• Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00003735Phase 2
• Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian CancerCompletedNCT00003732Phase 2
• Topotecan in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003675Phase 2
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic LeukemiaCompletedNCT00003619Phase 1/2
• Amifostine Plus Topotecan in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003415Phase 1/2
• Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube CancerTerminatedNCT00003382Phase 1
• Topotecan in Treating Patients With Recurrent Brain TumorsCompletedNCT00003372Phase 2
• Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous LeukemiaCompletedNCT00003340Phase 2
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003331Phase 1
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian CancerCompletedNCT00003297Phase 1/2
• Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung CancerCompletedNCT00003281Phase 2
• Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous LeukemiaCompletedNCT00003255Phase 2
• Ifosfamide and Topotecan in Treating Patients With Refractory Solid TumorsCompletedNCT00003198Phase 1
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid TumorsTerminatedNCT00003194Phase 1
• Topotecan in Treating Patients With Recurrent or Refractory Cancer of the UterusTerminatedNCT00003156Phase 2
• Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the CervixCompletedNCT00003065Phase 2
• Chemotherapy in Treating Patients With Recurrent Malignant GliomaCompletedNCT00002986Phase 1
• Topotecan Plus Sargramostim in Treating Patients With Advanced CancerCompletedNCT00002950Phase 1/2
• High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerTerminatedNCT00002948Phase 1
• Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian CancerCompletedNCT00002913Phase 1
• Combination Chemotherapy for Patients With Brain CancerCompletedNCT00002814Phase 2
• Topotecan in Treating Children With Refractory LeukemiaCompletedNCT00002705Phase 1
• Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute LeukemiaCompletedNCT00002693Phase 1
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal TumorCompletedNCT00002643Phase 2
• Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002625Phase 1
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory LeukemiaCompletedNCT00002588Phase 1
• Paclitaxel Plus Topotecan in Treating Patients With Solid TumorsCompletedNCT00002587Phase 1
• Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung CancerCompletedNCT00002537Phase 1
• Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)CompletedNCT00002395Phase 2
• Phase I Study of Intrathecal TopotecanCompletedNCT00001333Phase 1

← Topotecan overview